Since joining Kirkland, Dan has worked on the following matters, advising:
- The Apex Group on its acquisition of Edmond de Rothschild’s third-party asset servicing activities based in Luxembourg.
- Thoma Bravo on its acquisition of a majority stake in Hypergene, a Swedish SaaS company for planning and performance management.
- Thoma Bravo on the public takeover offer for EQS Group AG.
- Thoma Bravo and its portfolio company SailPoint on its take private of Osirium Technologies plc, a privileged access security business.
- The EQT-led consortium on the £4.5 billion recommended cash offer for Dechra Pharmaceuticals PLC.
- Thoma Bravo on the investment in LOGEX, a leading healthcare analytics provider and the inaugural investment by Thoma Bravo’s Europe-based team.
- Antin Infrastructure Partners on its acquisition of Wildstone.
- Recipharm, a portfolio company of EQT, on the acquisitions of Arranta Bio, a prominent advanced therapy CDMO, and Vibalogics, a virotherapy CDMO.
- Apex Fund Management, a portfolio company of TA Associates and Genstar, on the acquisition of the Maitland fund services business.
- GIC on the £694 million acquisition of a 75% stake in the majority of Paddington Central assets from British Land.
- Thoma Bravo on the strategic investment in Condeco, a global leader in workspace scheduling technology.
- Blackstone and Brown Bidco Limited on the $4.73 billion recommended take private of Signature Aviation.
- EQT VI on the sale of Anticimex, a global pest control specialist.
- E2Open on the $1.7 billion acquisition of BluJay Solutions, a leading international cloud-based, logistics execution platform.
- AJAX I on its $7 billion business combination with Cazoo Holdings Limited.
- TDR Capital on the acquisition of BPP, a global leader in professional and vocational education.
Prior to joining Kirkland, Dan worked on the following matters, advising:
- A private Qatari investor on the acquisition of The Ritz.
- A private equity fund on the sale of a renowned British publishing company.
- A private investor on the sale of a London hotel group.
